Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH) -- Ignore unavailable to you. Want to Upgrade?

To: Izzy who wrote (3266)	12/10/1997 2:01:00 PM
From: Richard Monge	Read Replies (1) \| Respond to of 6136

Izzy, In my option the stock is trying to find a bottom. Where this bottom is I'm not sure (maybe 27-29). Over the next few months there are two releases I feel may move the stock higher. These are its earnings (due in January ) and european approval for veracept (Feb, March??). As the earning go keep an eye on veracept's monthly script numbers and market share. If these two numbers are higher than last quarter's average and the market for PIs is constant or expanding, earnings should beat analyst projections.